RGBP
Regen BioPharma Inc
$0.00
+0.00 (+0.00%)
At close · Jul 7
Market Cap
$51,195
Shares
511,957,643
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$236.56K
0%
FY2025
Net Income
-$1.27M
-90.7%
FY2025
Operating Margin
-143.11%
+33.3pp
FY2025
Diluted EPS
-$0.05
+68.8%
FY2025
Operating Cash Flow
-$383.59K
+49%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $236.56K | $236.56K | $236.56K | $126.56K | $125.52K | $61.19K | $110K | $110K | $100K | $110K | $100K | $192K | $0 | — | |
| $56 | — | — | — | $455 | $230 | $0 | — | — | — | — | — | — | — | |
| — | $11.73K | $153.69K | $212.3K | $158.14K | $36.7K | $13.29K | $45.61K | $374.44K | $1.15M | $671.1K | $282.3K | $23.87K | $8394 | |
| $312.48K | $75.11K | $58.92K | $44.98K | $28.06K | $119.5K | $249.7K | $500.64K | $743.76K | $822.08K | $1.66M | $1.31M | $523.91K | $262.88K | |
| $1.11M | $575.1K | $653.78K | $923.51K | — | — | — | — | — | — | — | — | — | — | |
| $627.46K | — | — | $923.51K | $575.12K | $371.96K | $319.32K | $866.79K | $1.53M | $2.62M | $3.06M | $2.17M | $706.35K | $319.84K | |
| -$869.15K | -$338.54K | -$417.22K | -$686.95K | -$339.61K | -$200.77K | -$209.32K | -$756.79K | -$1.43M | -$2.51M | -$2.96M | -$1.98M | -$706.35K | -$319.84K | |
| — | -143.11% | -176.37% | -542.79% | -270.56% | -328.09% | -190.29% | -687.99% | -1425.78% | -2282.62% | -2956.96% | -1030.87% | — | — | |
| $164.55K | $158.29K | $72.45K | $58.58K | $138.72K | $316.01K | $333.41K | $295.17K | $259.07K | $98.8K | $27.82K | $21.69K | $2212 | $0 | |
| — | — | — | — | — | — | $0 | $1302 | — | — | — | — | — | — | |
| — | — | — | $1.84M | $2.78M | — | — | — | — | — | — | — | — | — | |
| -$715.69K | -$1.27M | -$668.26K | $1.16M | — | — | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$1.27M | -$668.26K | $1.16M | $2.44M | -$6.77M | $3.41M | -$2.62M | -$4.72M | -$5.84M | -$7.75M | -$11.2M | -$756.35K | -$355.03K | |
| — | -538.76% | -282.49% | 913.8% | 1946.77% | -11055.39% | 3104.02% | -2384.71% | -4715.2% | -5308.22% | -7750.59% | -5830.81% | — | — | |
| — | — | — | — | — | — | $0 | $0 | — | — | — | — | — | — | |
| — | — | -$668.26K | $1.02M | $2.23M | -$6.77M | $2.73M | -$2.62M | -$4.72M | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | -$4.75M | -$5.67M | — | -$11.23M | -$756.35K | — | |
| USD/shares | — | -$0.05 | -$0.16 | $0.29 | $0.36 | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$0.05 | -$0.16 | $0.29 | $0.36 | — | — | — | — | — | — | — | — | — |
| shares | — | 23.52M | 4.11M | 3.54M | 6.27M | 4.02M | 1.88M | 2.76M | 202.79K | 188.57K | 170.45K | 117.58K | 68.97K | 25.27K |
| shares | — | 23.52M | 4.11M | 3.54M | 6.27M | — | — | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
0.00×
Biotechnology median 7.60×